Insulet Corp (PODD)

Surgical & Medical Instruments & Apparatus

Latest Price

$130.47

TTM P/E

24.48

Normalized P/E

40.32

Div Yield

Book Value

20.53

P/B Ratio

6.35

Valuation metrics

EPS: $3.48

Book value / share: $21.53

Formula: √(22.5 × EPS × BVPS)

Graham Number

$41.05

69% downside

Norm. op. income: $126M (median of 7yr)

Tax rate: 24%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$10.62

92% downside

Base FCF: $305M (median of recent 5yr)

Growth: 24%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$304.78

+134% upside

EPS: $3.48

Target P/E: 40×

Formula: EPS × P/E

P/E Fair Value

$139.20

+7% upside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	6.69M	$1.02B	9.65%	+314.2K	2026-06-30
Vanguard Capital Management LLC	4.53M	$688.0M	6.53%	-53.9K	2026-06-30
State Street Corp	3.20M	$486.0M	4.61%	+155.1K	2026-06-30
Vanguard Portfolio Management LLC	3.08M	$468.0M	4.44%	-374.1K	2026-06-30
AQR Capital Management LLC	2.46M	$373.0M	3.54%	+856.4K	2026-06-30
Baillie Gifford & Co	2.04M	$310.0M	2.95%	+12.8K	2026-06-30
Geode Capital Management, LLC	2.00M	$303.0M	2.89%	-21.8K	2026-06-30
Two Sigma Investments, LP	1.90M	$289.0M	2.75%	--	2026-06-30
Invesco Ltd.	1.69M	$258.0M	2.45%	+598.1K	2026-06-30
T. Rowe Price Investment Management, Inc.	1.51M	$230.0M	2.18%	-303.6K	2026-06-30